HIV / AIDS
IAS 2017: PrEP Still Protected People Who Had Less Sex in Ipergay Study
- Details
- Category: HIV Prevention
- Published on Friday, 28 July 2017 00:00
A sub-study of the French Ipergay trial of "on-demand" pre-exposure prophylaxis (PrEP) has found that PrEP was just as effective for participants who had sex less often than average, and so took PrEP less often, as long as they did take it when it was needed. The analysis was presented by trial statistician Guillemette Antoni at the 9th International AIDS Society Conference (IAS 2017) conference this week in Paris.
IAS 2017: South African Child Has Controlled HIV Off Treatment for 8.5 Years
- Details
- Category: Search for a Cure
- Published on Friday, 28 July 2017 00:00
A 9-year-old South African child who was diagnosed with HIV infection at 1 month of age and received HIV treatment for 40 weeks during infancy has suppressed the virus without anti-HIV drugs for 8 and a half years, scientists reported this week at the 9th IAS Conference on HIV Science (IAS 2017) in Paris.
HR17: Combining Drug Addiction Treatment and Perinatal HIV Prevention Leads to Good Outcomes
- Details
- Category: Pregnancy & HIV MTCT
- Published on Wednesday, 31 May 2017 00:00
An integrated program offering medication-assisted drug addiction treatment and services aimed at preventing mother-to-child HIV transmission led to improved outcomes for opioid-dependent HIV-positive mothers and their babies, according to a presentation at the 25th Harm Reduction International Conference this month in Montreal.
IAS 2017: TAG Releases Annual HIV, Hepatitis C, and TB Pipeline Report
- Details
- Category: HIV Treatment
- Published on Friday, 21 July 2017 00:00
On July 18 the Treatment Action Group (TAG) announced the launch of its latest overview of investigational therapies for HIV, hepatitis C virus (HCV), and tuberculosis (TB).
Coverage of the 2017 Pediatric Academic Societies Meeting
- Details
- Category: HIV Treatment
- Published on Wednesday, 31 May 2017 00:00
HIVandHepatitis.com coverage of the 2017 Pediatric Academic Societies Meeting, May 6-9, 2017, in San Francisco.
- Many Doctors Wary of Providing PrEP for Young Patients
- Sofosbuvir Plus Ribavirin Cures Teens with Genotype 2 or 3 Hepatitis C
- Children on Immunosuppressive Therapy May Lose Hepatitis B Vaccine Protection
- Vaccine Reduces Human Papillomavirus Prevalence Among Young Women
- New Approaches Help Babies with Opioid Withdrawal Syndrome
IAS 2017: IAS Conference on HIV Science Starts Sunday in Paris
- Details
- Category: HIV Treatment
- Published on Friday, 21 July 2017 00:00
The 9th International AIDS Society (IAS) Conference on HIV Science will take place July 23-26 at the Palais des Congrèsin Paris. HIVandHepatitis.com and aidsmap will be providing joint on-site coverage next week. Follow breaking news via @HIVandHeptitis on Twitter. IAS will be webcasting plenary sessions and daily press conferences.
Coverage of the 2017 Harm Reduction International Conference
- Details
- Category: HIV Treatment
- Published on Wednesday, 31 May 2017 00:00
HIVand Hepatitis.com coverage of the 2017 Harm Reduction International Conference, May 14-17, 2017, in Montreal.
5/31/17
More Articles...
- PAS 2017: Many Doctors Wary of Providing PrEP for Young Patients
- Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections
- Coverage of the 2017 Conference on Retroviruses and Opportunistic Infections
- Obituary: Pioneering HIV Researcher Mark Wainberg
- HIV PrEP Is Approved in Scotland
Web Design and Development by